RLAY ▲ +3.6% - Relay Therapeutics, Inc.
$RLAY reported Q3 2026 EPS of -$0.37, beating the -$0.40 estimate by 7.5%. Revenue of $0 missed the $1.4M estimate by 100.0%.
04-NOV-2026 04:18 PM ET
Share this post
More filings for $RLAY
RLAY ▲ +3.6% - Relay Therapeutics, Inc.Nov 4, 2026RLAY ▼ -5.8% - Relay Therapeutics, Inc.Nov 2, 2026RLAY ▲ +4.5% - Relay Therapeutics, Inc.Oct 28, 2026RLAY ▲ +0.2% - Relay Therapeutics, Inc.Sep 1, 2026RLAY - Relay Therapeutics, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 10, 2026RLAY - Relay Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026
View full $RLAY filing history →💬 Comments
Loading comments…
Leave a comment